Phase II trial of nilotinib in PDGFR-alpha-enriched recurrent high-grade gliomas | NeoGenomics Laboratories

Publication date

Thu, 07/10/2025 - 12:00

Category

Year

External link

https://academic.oup.com/noa/article/7/1/vdaf150/8198388